近来报道:淋巴细胞活化可导致血清可溶性CD8(sCD8)、可溶性CD4(sCD4)和可溶性白细胞介素2受体(sIL-2R)水平升高,sCD8和sCD4是来源于活化的T 淋巴细胞,但slL-2R 也可由肿瘤细胞产生。急性髓性白血病(AML)患者血清中slL-2R 水平升高已有报道,但其来源和确切生物学作用不清楚。作者研究了27例AML:未经任何治疗的初诊者15例(M1 1例、M2 6例、M3 3例、M4 4例、M5 1例); Recently, it has been reported that lymphocyte activation results in elevated levels of serum soluble CD8 (sCD8), soluble CD4 (sCD4), and soluble interleukin 2 receptor (sIL-2R). sCD8 and sCD4 are derived from activated T lymphocytes, but slL-2R can also be produced by tumor cells. Serum levels of slL-2R in patients with acute myeloid leukemia (AML) have been reported, but their source and exact biological role are unclear. The authors studied 27 cases of AML: 15 patients without any treatment (M1 1 case, M2 6 cases, M3 3 cases, M4 4 cases, M5 1 case);